Answers are grounded in this paper and cite their sources.
Dibutyryl 3',5'-AMP, an analogue of 3',5'-AMP, mimics some of the actions of thyroid-stimulating hormone (TSH) on the thyroid. Both substances increase glucose-1-14C oxidation to 14CO2 in the dog. Dibutyryl 3',5'-AMP is active over the range of 10 to 250 µg per ml. Dibutyryl 3',5'-AMP, like low concentrations of TSH, decreases glucose-1-14C oxidation in bovine thyroid, and both substances increase 32Pi incorporation into phospholipid in bovine thyroid, although the dibutyryl 3',5'-AMP effect can only be detected in 50% of the experiments. However, unlike TSH, dibutyryl 3',5'-AMP fails to increase the incorporation of 32Pi or inositol-3H into phospholipid in dog thyroid slices. It also fails to increase glucose-1-14C oxidation to 14CO2 in rat thyroids. The significance of these findings in relation to the proposed role of 3',5'-AMP as the intracellular mediator of TSH action is discussed. The increase in glucose oxidation produced by TSH and dibutyryl 3',5'-AMP in normal dog thyroid slices fails to occur in lecithinase C-treated slices. Thus the site of lecithinase C action is probably distal to the site of action of TSH and dibutyryl 3',5'-AMP. TSH also fails to increase phospholipid turnover in lecithinase C-treated slices.
No takes yet. Share an insight, caveat, or question.
Pastan et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: